Humacyte, Inc. (HUMAW)
NASDAQ: HUMAW · Real-Time Price · USD · Warrants
0.1889
+0.0269 (16.60%)
At close: Aug 22, 2025, 4:00 PM
0.1940
+0.0051 (2.72%)
After-hours: Aug 22, 2025, 5:01 PM EDT

Company Description

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.

It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes.

The company was founded in 2004 and is headquartered in Durham, North Carolina.

Humacyte, Inc.
Humacyte logo
CountryUnited States
Founded2004
IndustryBiotechnology
SectorHealthcare
Employees220
CEOLaura Niklason

Contact Details

Address:
2525 East North Carolina Highway 54
Durham, North Carolina 27713
United States
Phone919 313 9633
Websitehumacyte.com

Stock Details

Ticker SymbolHUMAW
ExchangeNASDAQ
Stock TypeWarrants
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001818382
CUSIP Number44486Q111
ISIN NumberUS44486Q1114

Key Executives

NamePosition
Dr. Laura E. Niklason M.D., Ph.D.Founder, President, Chief Executive Officer and Director
Dale A. SanderChief Financial Officer, Chief Corporate Development Officer and Treasurer
Sabrina Osborne GPHR, SPHRChief People Officer
William John ScheesseleChief Commercial Officer
Dr. Shamik J. Parikh M.D.Chief Medical Officer
Dr. Yang Cao M.D., Ph.D.Chief Regulatory Officer
Lisa MolyneuxExecutive Vice President of Enterprise Planning and Analysis
Dr. Heather Connelly Ph.D.Senior Vice President of Quality